VKH
AGRX

Virtu KCG Holdings’s Agile Therapeutics AGRX Stock Holding History

Virtu KCG Holdings’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$48K Hold
6
– – ﹤0.01% 2601
2017
Q1 		$36K Buy
+6
New +$30.2K ﹤0.01% 2898
2014
Q3 		– Sell
-6
Closed -$108K – 4200
2014
Q2 		$108K Buy
+6
New +$86.8K ﹤0.01% 3279

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Virtu KCG Holdings's AGRX Position: Q2 2017 in Review

Virtu KCG Holdings held its Agile Therapeutics (AGRX) position steady in Q2 2017 at 6 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #2601.

Virtu KCG Holdings first reported a position in AGRX in Q2 2014 and has held it in 3 quarters since. The position peaked at $108K in Q2 2014. 41 funds tracked by Wall St. Rank hold AGRX as of Q2 2017.

  • Virtu KCG Holdings held 6 shares of Agile Therapeutics worth $48K as of Q2 2017.
  • Virtu KCG Holdings left its Agile Therapeutics share count unchanged in Q2 2017.
  • Agile Therapeutics made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2601 holding.
  • Virtu KCG Holdings first reported a position in Agile Therapeutics in Q2 2014 and has held it in 3 quarters since.
  • Virtu KCG Holdings's Agile Therapeutics position peaked at $108K in Q2 2014.
  • 41 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.